Volumetric Feasibility of Lumbar Artery Perforator Flaps Compared to Abdominal Flaps for Breast Reconstruction in Low-BMI Patients: A CT-Based Study

BACKGROUND: Although abdominal flaps remain the gold standard for autologous breast reconstruction, their use in low-BMI patients-particularly in bilateral cases or when matching a contralateral large breast-can be limited by concerns about insufficient volume. The lumbar artery perforator (LAP) flap has emerged as a potential alternative. This study evaluated its volumetric adequacy in lean patients using computed tomographic angiography (CTA)-based analysis. METHODS: Between 2019 and 2024, patients with BMI ≤ 25 who underwent abdominal flap-based breast reconstruction were retrospectively reviewed. Flap volumes were assessed using CTA. LAP flap volumes were compared with (1) 50% of estimated abdominal flap volume to simulate bilateral reconstruction and (2) estimated abdominal flap volumes based on inset rates from bipedicled cases. Comparisons were stratified by BMI: < 23 and 23-25. RESULTS: A total of 177 patients were included. The estimated abdominal and LAP flap volumes were 695.0 and 486.6 cm3, respectively, both positively correlated with BMI. The LAP-to-abdominal flap volume ratio increased as BMI decreased. LAP flap volume exceeded 1.0 relative to 50% of abdominal volume in over 90% of cases, especially in the BMI < 23 group. In bipedicled DIEP flap cases, the average abdominal inset ratio was 0.84; accordingly, the adjusted LAP-to-abdominal flap volume ratio was 0.87 overall and 0.92 in the BMI < 23 group. CONCLUSIONS: The LAP flap volume was found to be comparable to that of the abdominal flap in a meaningful proportion of lean patients. These findings suggest it may serve as a reasonable alternative in cases requiring bilateral or bipedicled abdominal flap reconstruction. LEVEL OF EVIDENCE III: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Peer-reviewed clinical and outcomes research relevant to medicinal leech therapy and its biology. Indexed in PubMed and verified against the NCBI record.

Узнайте, как это исследование связано с клинической практикой

More peer-reviewed studies in Клинические исследования.

• Leech Therapy for Knee Osteoarthritis — The Landmark RCT — Michalsen et al. (2003)
• Leech-Assisted Flap Salvage — Systematic Review of 277 Cases — Whitaker et al. (2012)
• Effects of hirudotherapy on liver functions, lipid profile, and insulin sensitivity in rats with metabolic syndrome — Bilden A et al. (2026)
• HIRUDOTHERAPY IN PRESBYACUZIS PRAECOX IN CLEAN-UP WORKERS AFTER THE CHORNOBYL ACCIDENT DURING THE POST-CATASTROPHE YEARS — Zabolotnyi D, Mishchanchuk N (2019)
• Wound healing potential of bark paste of Pongamia pinnata along with hirudotherapy: A case report — Balasooriya D, Karunarathna C, Uluwaduge I (2021)
• AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech — Baranzini N et al. (2019)
• Study on the effect of medicinal leech therapy (Hirudo medicinalis) on full-thickness excisional wound healing in the animal model — Zakian A et al. (2022)
• [Hirudo medicinalis-leech applications in plastic and reconstructive microsurgery--a literature review] — Knobloch K et al. (2007)
• The duration of rest and feeding greatly affects the re-breeding of ectoparasites: Hirudo verbana, Hirudo medicinalis and Hirudo orientalis — Aminov R, Frolov A, Aminova A (2022)
• Recombinant hirudin in clinical practice: focus on lepirudin — Greinacher A, Lubenow N (2001)

Browse all ASH-analysed research →